X
Biogen signs $2.1 billion Parkinson’s disease deal with Denali
https://pharmaphorum.com/news/biogen-signs-2-1-billion-parkinsons-disease-deal-with-denali/
Denali
F-star and Denali sign potential $1bn antibody deal
Deal focuses on CNS bispecific antibodies.